The aim of this study was to determine whether educational length affects prostate-specific antigen (PSA) testing and the time to prostate biopsy for men with raised PSA values.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Using register data on all men in Stockholm County in 2013 (n = 1,052,841), the limited-duration point prevalence of PSA testing and time between test and prostate biopsy or repeat testing were analysed.
Patterns of follow-up were assessed using Kaplan-Meier product limit estimators and Cox proportional hazard models. Educational length was categorized as short (≤9 years), intermediate (10-12 years) or long (≥13 years).
PSA testing increased with educational length in all age groups. Among men aged 50-69 years, 61% with long and 54% with short education had had a PSA test within the preceding 10 years (p < 0. 001). In men with PSA 4-10 ng/ml, 40% [95% confidence interval (CI) 38-41] with long and 27% (95% CI 26-29) with short education underwent a prostate biopsy within 12 months. After adjusting for PSA level and age, educational length was still associated with the chance of having a prostate biopsy in men with PSA 4-10 ng/ml (hazard ratio 1. 22, 95% CI 1. 12-1. 31), but not in men with higher PSA values.
PSA testing increased with educational length. Men with long education were more likely to have a prostate biopsy after an increased PSA value below 10 ng/ml than men with short education. These differences may contribute to the worse prostate cancer outcomes observed among men with lower socioeconomic status.
Scandinavian journal of urology. 2015 Dec 01 [Epub ahead of print]
Tobias Nordström, Ola Bratt, Joakim Örtegren, Markus Aly, Jan Adolfsson, Henrik Grönberg
a Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden ;, d Urological Cancer Research Unit, Department of Translational Medicine , Lund University , Lund , Sweden ;, d Urological Cancer Research Unit, Department of Translational Medicine , Lund University , Lund , Sweden ;, a Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden ;, f Karolinska Institutet , Department of Clinical Science, Intervention and Technology (CLINTEC) , Stockholm , Sweden ;, a Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden ;